| Cloned (Comment) | Organism |
|---|---|
| expression in Escherichia coli | Homo sapiens |
| expression in Escherichia coli | Rattus norvegicus |
| Crystallization (Comment) | Organism |
|---|---|
- |
Homo sapiens |
- |
Rattus norvegicus |
| Inhibitors | Comment | Organism | Structure |
|---|---|---|---|
| 2-ethyl-7-(3-hydroxy-3-methylpyrrolidin-1-yl)-5-(trifluoromethyl)-1H-pyrrolo[3,2-b]pyridine-6-carbonitrile | - |
Homo sapiens | |
| 3-(trifluoromethyl)quinoxalin-2(1H)-one | - |
Homo sapiens | |
| 4,6-dimethyl-2-(morpholin-4-yl)pyridine-3-carbonitrile | - |
Homo sapiens | |
| 6-[(3S,4S)-3,4-dihydroxypyrrolidin-1-yl]-2-[(3S)-3-hydroxy-3-methylpyrrolidin-1-yl]-4-(trifluoromethyl)pyridine-3-carbonitrile | nonbasic moderately potent and highly selective ketohexokinase inhibitor | Homo sapiens | |
| 6-[(3S,4S)-3,4-dihydroxypyrrolidin-1-yl]-2-[(3S)-3-hydroxy-3-methylpyrrolidin-1-yl]-4-(trifluoromethyl)pyridine-3-carbonitrile | nonbasic moderately potent and highly selective ketohexokinase inhibitor with favorable ADME and safety profiles and good exposure in rats | Rattus norvegicus | |
| 6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-[(3S)-3-hydroxy-3-methylpyrrolidin-1-yl]-4-(trifluoromethyl)pyridine-3-carbonitrile | - |
Homo sapiens | |
| 6-[4-(2-hydroxyethyl)piperazin-1-yl]-4-[3-(hydroxymethyl)piperidin-1-yl]-2-(trifluoromethyl)pyridine-3-carbonitrile | - |
Homo sapiens | |
| 7-[(3R)-3-hydroxy-3-methylpyrrolidin-1-yl]-5-(trifluoromethyl)-1H-pyrrolo[3,2-b]pyridine-6-carbonitrile | - |
Homo sapiens | |
| 7-[(3S)-3-hydroxy-3-methylpyrrolidin-1-yl]-5-(trifluoromethyl)-1H-pyrrolo[3,2-b]pyridine-6-carbonitrile | - |
Homo sapiens | |
| 7-[(3S)-3-hydroxy-3-methylpyrrolidin-1-yl]-5-(trifluoromethyl)-1H-pyrrolo[3,2-b]pyridine-6-carbonitrile | - |
Rattus norvegicus | |
| [(3R)-1-(5-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-3-yl]methanol | - |
Homo sapiens |
| Organism | UniProt | Comment | Textmining |
|---|---|---|---|
| Homo sapiens | P50053 | - |
- |
| Rattus norvegicus | Q02974 | - |
- |
| Purification (Comment) | Organism |
|---|---|
- |
Homo sapiens |
- |
Rattus norvegicus |
| Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
|---|---|---|---|---|---|---|
| ATP + D-fructose | - |
Homo sapiens | ADP + D-fructose 1-phosphate | - |
? | |
| ATP + D-fructose | - |
Rattus norvegicus | ADP + D-fructose 1-phosphate | - |
? |
| Synonyms | Comment | Organism |
|---|---|---|
| KHK | - |
Homo sapiens |
| KHK | - |
Rattus norvegicus |
| IC50 Value | IC50 Value Maximum | Comment | Organism | Inhibitor | Structure |
|---|---|---|---|---|---|
| 0.00039 | - |
23°C, pH 7.4, splice variant KHK-A | Homo sapiens | 6-[(3S,4S)-3,4-dihydroxypyrrolidin-1-yl]-2-[(3S)-3-hydroxy-3-methylpyrrolidin-1-yl]-4-(trifluoromethyl)pyridine-3-carbonitrile | |
| 0.00045 | - |
23°C, pH 7.4, splice variant KHK-C | Homo sapiens | 6-[(3S,4S)-3,4-dihydroxypyrrolidin-1-yl]-2-[(3S)-3-hydroxy-3-methylpyrrolidin-1-yl]-4-(trifluoromethyl)pyridine-3-carbonitrile | |
| 0.00064 | - |
23°C, pH 7.4 | Rattus norvegicus | 7-[(3S)-3-hydroxy-3-methylpyrrolidin-1-yl]-5-(trifluoromethyl)-1H-pyrrolo[3,2-b]pyridine-6-carbonitrile | |
| 0.00067 | - |
23°C, pH 7.4 | Homo sapiens | 7-[(3S)-3-hydroxy-3-methylpyrrolidin-1-yl]-5-(trifluoromethyl)-1H-pyrrolo[3,2-b]pyridine-6-carbonitrile | |
| 0.00103 | - |
23°C, pH 7.4 | Homo sapiens | 6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-[(3S)-3-hydroxy-3-methylpyrrolidin-1-yl]-4-(trifluoromethyl)pyridine-3-carbonitrile | |
| 0.00148 | - |
23°C, pH 7.4 | Homo sapiens | 2-ethyl-7-(3-hydroxy-3-methylpyrrolidin-1-yl)-5-(trifluoromethyl)-1H-pyrrolo[3,2-b]pyridine-6-carbonitrile | |
| 0.01679 | - |
23°C, pH 7.4 | Homo sapiens | 6-[4-(2-hydroxyethyl)piperazin-1-yl]-4-[3-(hydroxymethyl)piperidin-1-yl]-2-(trifluoromethyl)pyridine-3-carbonitrile | |
| 0.02421 | - |
23°C, pH 7.4 | Homo sapiens | 7-[(3R)-3-hydroxy-3-methylpyrrolidin-1-yl]-5-(trifluoromethyl)-1H-pyrrolo[3,2-b]pyridine-6-carbonitrile | |
| 0.1 | - |
23°C, pH 7.4 | Homo sapiens | 3-(trifluoromethyl)quinoxalin-2(1H)-one | |
| 0.118 | - |
23°C, pH 7.4 | Homo sapiens | [(3R)-1-(5-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-3-yl]methanol | |
| 0.319 | - |
23°C, pH 7.4 | Homo sapiens | 4,6-dimethyl-2-(morpholin-4-yl)pyridine-3-carbonitrile |
| General Information | Comment | Organism |
|---|---|---|
| metabolism | increased fructose consumption and its subsequent metabolism are implicated in hepatic steatosis, dyslipidemia, obesity, and insulin resistance | Homo sapiens |
| metabolism | increased fructose consumption and its subsequent metabolism are implicated in hepatic steatosis, dyslipidemia, obesity, and insulin resistance | Rattus norvegicus |